Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Hyalase for Failed Back Surgery Syndrome
NCT05349448Phase 1Unknown
- Sponsor
- Minia University
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in failed back surgery syndrome (FBSS), sponsored by Minia University. Primary endpoint: Pain assessment at 6 months. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
failed back surgery syndrome (FBSS)
Beyond the preview
Go deeper on NCT05349448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05349448.